Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 5
1968 2
1969 5
1970 3
1971 10
1972 4
1973 4
1974 3
1975 6
1976 7
1977 3
1978 5
1979 3
1980 3
1981 1
1982 2
1983 9
1984 4
1985 4
1986 6
1987 6
1988 2
1989 10
1990 5
1991 3
1992 2
1993 8
1994 4
1995 6
1996 6
1997 3
1998 5
2000 4
2001 4
2002 3
2003 1
2004 1
2005 1
2006 1
2013 2
2015 1
2016 1
2017 2
2018 3
2019 2
2020 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Interventional nuclear medicine.
McCready VR, Dizdarevic S, Aplin M. McCready VR, et al. Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1044-6. doi: 10.1007/s00259-013-2413-z. Eur J Nucl Med Mol Imaging. 2013. PMID: 23640468 No abstract available.
Thyrotoxicosis is no insurance against thyroid cancer.
Dizdarevic S, McCready VR, Skalonja M. Dizdarevic S, et al. Among authors: mccready vr. Eur J Nucl Med Mol Imaging. 2024 Jan 4. doi: 10.1007/s00259-023-06580-y. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38172355 No abstract available.
Reply to 'Single high dose versus repeated bone-targeted radionuclide therapy'.
Denis-Bacelar AM, Chittenden SJ, Dearnaley DP, Divoli A, O'Sullivan JM, McCready VR, Johnson B, Du Y, Flux GD. Denis-Bacelar AM, et al. Among authors: mccready vr. Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):515-517. doi: 10.1007/s00259-017-3902-2. Eur J Nucl Med Mol Imaging. 2018. PMID: 29247283 No abstract available.
Lesion Detection and Administered Activity.
McCready VR, Dizdarevic S, Beyer T. McCready VR, et al. J Nucl Med. 2020 Sep;61(9):1406-1410. doi: 10.2967/jnumed.120.244020. Epub 2020 Apr 3. J Nucl Med. 2020. PMID: 32245895 Free article. No abstract available.
Tumour imaging radiopharmaceuticals.
Paterson AH, McCready VR. Paterson AH, et al. Among authors: mccready vr. Br J Radiol. 1975 Jul;48(571):520-31. doi: 10.1259/0007-1285-48-571-520. Br J Radiol. 1975. PMID: 50109 Review.
FDG accumulation and tumor biology.
Pauwels EK, Ribeiro MJ, Stoot JH, McCready VR, Bourguignon M, Mazière B. Pauwels EK, et al. Among authors: mccready vr. Nucl Med Biol. 1998 May;25(4):317-22. doi: 10.1016/s0969-8051(97)00226-6. Nucl Med Biol. 1998. PMID: 9639291 Free article. Review.
Spleen scanning.
McCready VR, Ahuja S. McCready VR, et al. Proc R Soc Med. 1969 Aug;62(8):794-6. Proc R Soc Med. 1969. PMID: 5810286 Free PMC article. No abstract available.
The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma.
Dizdarevic S, Tulchinsky M, McCready VR, Mihailovic J, Vinjamuri S, Buscombe JR, Lee ST, Frangos S, Sathekge M, Siraj Q, Choudhury P, Bom H, Franceschi M, Ugrinska A, Paez D, Hussain R, Mailman J, Luster M, Virgolini I; WARMTH Thyroid Group. Dizdarevic S, et al. Among authors: mccready vr. World J Nucl Med. 2019 Apr-Jun;18(2):123-126. doi: 10.4103/wjnm.WJNM_117_18. World J Nucl Med. 2019. PMID: 31040741 Free PMC article. No abstract available.
Thyroid cancer: differentiated carcinoma.
Harmer CL, McCready VR. Harmer CL, et al. Among authors: mccready vr. Cancer Treat Rev. 1996 May;22(3):161-77. doi: 10.1016/s0305-7372(96)90001-8. Cancer Treat Rev. 1996. PMID: 8841389 Review. No abstract available.
179 results